Author: Dr Clemens

Uncategorized Published - 21 February, 2024    By - Dr Clemens
Naloxone for Opioid Overdose: Reply

Authors: Maarten van Lemmen, B.Sc. et al  Anesthesiology February 2024. In Reply: We thank Dr. Pattullo and Drs. Milas and Varon for their interest and careful reading of our article on the use of naloxone in the reversal of an opioid overdose as might occur in the community setting in the United States. Individuals that […]

Read More
Uncategorized Published - 21 February, 2024    By - Dr Clemens
Naloxone for Opioid Overdose: Comment

Author: Gavin G. Pattullo, F.A.N.Z.C.A., F.F.P.M.A.N.Z.C.A. Anesthesiology February 2024. To the Editor: As clinicians, we often question why some patients respond to naloxone and others do not when opioid-induced ventilatory impairment is suspected. This inexplicability is disconcerting, given the toll of opioid-induced ventilatory impairment–related deaths. Our search for greater understanding, as recently provided in this […]

Read More
Uncategorized Published - 21 February, 2024    By - Dr Clemens
Naloxone for Opioid Overdose: Comment

Authora: Bonnie L. Milas, M.D. et al  Anesthesiology February 2024. To the Editor: As ASA members spearheading the REVIVEme.com initiative, we appreciate the thorough review of naloxone’s pharmacokinetics and dynamics by Lemmen et al. and the focus it brings to our Journal’s readers. It is clear that further study of opioid overdose reversal of respiratory depression […]

Read More
Uncategorized Published - 21 February, 2024    By - Dr Clemens
Disputes over surprise billing continue to soar, new CMS data shows

Author: Rebecca Pifer HealthcareDive Arbiters are mostly selecting the higher payment offer in billing dispute determinations. That suggests No Surprises could actually raise premiums for consumers, one health researcher said. Dive Brief: The federal government received 13 times more surprise billing disputes in the first half of 2023 than it expected to receive in a […]

Read More
Uncategorized Published - 21 February, 2024    By - Dr Clemens
How can physicians become world-class leaders?

AUTHOR: ARTHUR LAZARUS, MD, MBA KevinMD.com Following a Congressional hearing into antisemitic harassment on the campuses of Harvard, MIT, and the University of Pennsylvania, there were several changes in leadership at Penn. Jonathan A. Epstein, MD, was named interim dean at Penn’s Perelman School of Medicine, replacing J. Larry Jameson, MD, PhD, who became interim […]

Read More
Uncategorized Published - 20 February, 2024    By - Dr Clemens
HOW LONG WILL IT TAKE ME TO WAKE UP FROM GENERAL ANESTHESIA?

Author: Richard Novak, MD The Anesthesia Consultant One of the most frequent questions I hear from patients before surgery is, “How long will it take me to wake up from general anesthesia?” The answer is, “It depends.” Your wake up from general anesthesia depends on: What drugs the anesthesia provider uses How long your surgery […]

Read More
Uncategorized Published - 20 February, 2024    By - Dr Clemens
Achieving Competency in Fiber-Optic Intubation Among Resident Physicians After Higher- Versus Lower-Fidelity Task Training

AUTHORS: Melvin, Martina T. FCAI et al  Anesthesia & Analgesia 137(1):p 200-208, July 2023. BACKGROUND: The high-fidelity ORSIM (Airway Simulation Ltd) and the low-fidelity wooden-block fiber-optic task trainers allow users to familiarize themselves with the psychomotor skills required to manipulate the fiber-optic scope. METHODS: This single-center study aimed to compare residents’ performance of fiber-optic intubation after […]

Read More
Uncategorized Published - 20 February, 2024    By - Dr Clemens
Analgesic Effect of Buprenorphine for Chronic Noncancer Pain

AUTHORS: Wong, Stanley Sau Ching MD et al  Anesthesia & Analgesia 137(1):p 59-71, July 2023. BACKGROUND: Buprenorphine is a partial agonist at the µ-opioid receptor and an antagonist at the delta and kappa opioid receptors. It has high affinity and low intrinsic activity at the µ-opioid receptor. Buprenorphine demonstrates no ceiling effect for clinical analgesia but […]

Read More
Uncategorized Published - 20 February, 2024    By - Dr Clemens
Salt substitutes reduce hypertension risk by up to 40%

Author: Michael Walter Cardiovascular Business Salt substitutes are associated with a reduced risk of high blood pressure without increasing the risk of low blood pressure, according to new findings published in the Journal of the American College of Cardiology.[1] “Adults frequently fall into the trap of consuming excess salt through easily accessible and budget-friendly processed foods,” […]

Read More
Uncategorized Published - 20 February, 2024    By - Dr Clemens
Independent ASC market share shrinks further

Authors: Patsy Newitt Becker’s ASC Review The percentage of ASCs that are independent shrunk from 70% to 68% from 2022 to 2023, according to a February report from VMG Health. Here are three more notes on ASC consolidation: 1. Because of the highly fragmented industry, there’s room for ASC consolidation at the individual facility level, according to […]

Read More